Association of physical activity with quality of life, clinical symptoms and inflammatory Status in patients with inflammatory bowel disease
- Conditions
- K50K51Crohn disease [regional enteritis]Ulcerative colitis
- Registration Number
- DRKS00011370
- Lead Sponsor
- Medizinische Hochschule Hannover
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
• Male and female patients aged =18 years
• Known chronic inflammatory disease (> 3 months)
• belonging to a collective
A) CED with moderate - high clinical activity
B) CED in Remission
• Written consent of the patient after clarification
• Compulsive disorder, which according to the physician's opinion significantly limits the physical activity (eg, cardiopulmonary, movement apparatus)
• Diseases which do not allow the person concerned to assess the nature and scope and possible consequences of the clinical trial
• Signs that the patient is unlikely to comply with the protocol (eg lack of co-operation)
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Characterization of habitual physical activity in patients with chronic inflammatory diseases via questionnaire PRO-2 and HBI/SCDAI (M. Crohn) and SSCAI (Colitis ulcerosa).
- Secondary Outcome Measures
Name Time Method • Physical activity in CED patients in remission or at moderately high inflammatory activity compared to control subjects<br>• Assess the quality of life as a function of physical activity and disease status<br>• Analysis of the relationship nutritional condition - physical activity in CED patients<br>• Assess the relationship between physical activity - CED disease activity and vitamin D metabolism.<br>Survey of the quality of life under CED with the questionnaire IBD-Q. Assessment of nutritional habits using the nutritional questionnaire DEGS-FFQ. Collection of habitual physical activity using the Freiburg questionnaire on physical activity.